Efficacy and safety of fentanyl pectin nasal spray compared with immediate-release morphine sulfate tablets in the treatment of breakthrough cancer pain: a multicenter, randomized, controlled, double-blind, double-dummy multiple-crossover study

Fentanyl Nasal Spray Study 044 Investigators Group, Marie Fallon, Carlo Reale, Andrew Davies, A Eberhard Lux, Kirushna Kumar, Andrzej Stachowiak, Rafael Galvez

Research output: Contribution to journalArticlepeer-review

Abstract

Immediate-release morphine sulfate (IRMS) remains the standard treatment for breakthrough cancer pain (BTCP), but its onset of effect does not match the rapid onset and short duration of most BTCP episodes.
Original languageEnglish
Pages (from-to)224-31
Number of pages8
JournalThe Journal of Supportive Oncology
Volume9
Issue number6
DOIs
Publication statusPublished - 2012

Fingerprint

Dive into the research topics of 'Efficacy and safety of fentanyl pectin nasal spray compared with immediate-release morphine sulfate tablets in the treatment of breakthrough cancer pain: a multicenter, randomized, controlled, double-blind, double-dummy multiple-crossover study'. Together they form a unique fingerprint.

Cite this